COMMUNIQUÉS West-GlobeNewswire

REPEAT -- Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion
11/08/2025
Treatment of a subgroup of patients with post-acute sequelae of SARS-CoV-2. Forecast adds to Tevogen Bio's Oncology therapeutic area projections of $1 billion in the launch year and $10–$14 billion over the first five [...]
Esteworld Opens First UK Representative Office in London’s Covent Garden
11/08/2025
Photo: Esteworld Opens Its First Representative Office in the UK in London LONDON, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Turkish aesthetic healthcare group Esteworld has strengthened its presence in the UK market with the [...]
BHIANT Quarterly Update: North Texas Bio Innovation Gains Momentum with Workforce Development and Industry Collaboration
11/08/2025
DALLAS, Aug. 11, 2025 (GLOBE NEWSWIRE) -- BHIANT , the workforce development arm of BioNTX, is charting new ground in biotechnology talent development and industry collaboration, strengthening North Texas’ position as a [...]
Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow
11/08/2025
Total eligible patients in the US exceed 2 million. Treatment of SARS-CoV-2 infection in solid and hematologic cancer patients under active treatment. Reflects business philosophy of commercial success through patient [...]
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Second Quarter 2025 Financial Results on August 14, 2025
11/08/2025
FREDERICK, Md., Aug. 11, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report [...]
NTG Nordic Transport Group publishes interim report for H1 2025
11/08/2025
Company announcement no. 9 – 25 11 August 2025 NTG Nordic Transport Group publishes interim report for H1 2025 The interim report for H1 2025 is enclosed. In connection with publication of the results for H1 2025, a [...]
Rising Cyber Threats to Brazil’s Health Sector Highlighted in New Health-ISAC Report
11/08/2025
Attacks on Brazil’s health system are rising, and limited intelligence sharing is contributing to put patient data and critical infrastructure at risk. ORLANDO, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Health-ISAC, a non [...]
Managed Healthcare Executive® announces 2025 PBMI Innovators Award winners
11/08/2025
Celebrating six visionaries driving meaningful innovation in pharmacy benefit management CRANBURY, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Managed Healthcare Executive® is proud to announce the winners of the 2025 PBMI [...]
TOMI Environmental Solutions Secures Order from ARES Distribution
11/08/2025
FREDERICK, Md., Aug. 11, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced that it has [...]
REPEAT - Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
11/08/2025
WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a [...]
PharmaTher Announces FDA Approval of Ketamine (KETARx™)
11/08/2025
TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of [...]
BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results
11/08/2025
SUNNYVALE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported [...]
Artelo Biosciences Receives Notice of Allowance from European Patent Office for the Patent Claims for the Intended Commercial Formulation of ART27.13
11/08/2025
Extends Patent Protection Through December 2041 ART27.13 is Currently under Evaluation in a Phase 2 Study for the Treatment of Cancer-Related Anorexia SOLANA BEACH, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Artelo [...]
Windtree Announces Istaroxime has been Chosen for a Plenary Session Presentation at the Heart Failure Society of America 2025
11/08/2025
Presentation will be the interim data from the Phase 2 study of istaroxime in SEISMiC C - Cardiogenic Shock SCAI Stage C Cardiogenic shock SCAI Stage C has an in hospital mortality rate of 20-30% Istaroxime interim data [...]
FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy
11/08/2025
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics
11/08/2025
- Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right - EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a [...]
Oragenics Q2 2025 Shareholder Update
11/08/2025
Advancing Brain-First Recovery Platform Toward Clinical Milestones Pioneering Intranasal Therapeutics for Concussion SARASOTA, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering [...]
Veru Announces Selection of Novel Modified Release Oral Enobosarm Formulation for Chronic Weight Loss Management Following Pharmacokinetic Clinical Study
11/08/2025
MIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory [...]
Safety Shot Announces Strategic Alliance with Bonk Founding Contributors, Initiating BONK Treasury Strategy
11/08/2025
Company to Receive $25 Million in BONK Tokens from Founding Contributors of BONK, Establishing a New Model for Public Company Participation in DeFi SCOTTSDALE, AZ, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. ( [...]

Pages